Skip to main navigation
Skip to search
Skip to main content
Research Profiles at Washington University School of Medicine Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
Intratumoral metabolic heterogeneity of cervical cancer
Elizabeth A. Kidd,
Perry W. Grigsby
Institute of Clinical and Translational Sciences (ICTS)
Division of Nuclear Medicine
Research output
:
Contribution to journal
›
Article
›
peer-review
139
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Intratumoral metabolic heterogeneity of cervical cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Adaptive Thresholding
25%
Cervical Cancer
100%
Cervical Tumor
25%
Cervix
50%
Chemoradiation
25%
Disease Outcome
25%
F-18 Fluorodeoxyglucose Positron Emission Tomography
25%
Fluorodeoxyglucose
50%
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
100%
Image Segmentation
25%
International Federations
25%
Intratumoral Heterogeneity
25%
Lymph Node Involvement
25%
Lymph Node Metastasis
25%
Metabolic Heterogeneity
100%
Obstetrics
25%
Patient Outcomes
25%
Pelvic Recurrence
50%
Positron Emission Tomography/computerized Tomography
25%
Progression-free Survival
25%
Prospective Cohort Study
25%
Response to Radiation
25%
Response to Therapy
25%
Risk Response
25%
Specific Factors
25%
Specific Patient
25%
Standardized Uptake Value
25%
Three-dimensional (3D)
25%
Threshold Function
25%
Tumor
50%
Tumor Heterogeneity
25%
Tumor Histology
25%
Tumor Response
25%
Tumor Volume
50%
Tumor-specific
25%
Volume Threshold
25%
Working Diagnosis
50%
Medicine and Dentistry
Cervical Cancer
100%
Chemoradiotherapy
16%
Computer Assisted Tomography
16%
Diseases
16%
Fluorodeoxyglucose
100%
Fluorodeoxyglucose F 18
16%
Gynecology
16%
Lymph Node
16%
Lymph Node Metastasis
16%
Neoplasm
66%
Obstetrics
16%
Pelvis
33%
Positron Emission Tomography
83%
Progression Free Survival
16%
Prospective Cohort Study
16%
Recurrent Disease
33%
Specific Tumor
16%
Standardized Uptake Value
16%
Tumor Histology
16%
Uterine Cervix Tumor
33%
Pharmacology, Toxicology and Pharmaceutical Science
Chemoradiation Therapy
16%
Diseases
16%
Fluorodeoxyglucose
100%
Fluorodeoxyglucose F 18
16%
Lymph Node Metastasis
16%
Neoplasm
100%
Progression Free Survival
16%
Prospective Cohort Study
16%
Recurrent Disease
33%
Uterine Cervix Cancer
100%
Uterine Cervix Tumor
33%
Immunology and Microbiology
Computer Assisted Tomography
20%
Lymph Node
40%
Pelvis
40%
Positron Emission Tomography
100%
Progression Free Survival
20%
Tumor Volume
40%